Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Trading Update

10 Oct 2024 07:00

RNS Number : 6181H
Centaur Media PLC
10 October 2024
 

Centaur Media plc

Incorporated in England and Wales

Registration number: 04948078

LEI: 2138005WK87G7DQRQI62

ISIN: GB0034291418

 

10 October 2024

Centaur Media Plc

("Centaur" or "the Company")

 

Trading Update

 

Centaur, an international provider of business intelligence, learning and specialist consultancy, provides a trading update.

 

As highlighted in the interim results in July, the marketing sector headwinds caused by macro-economic challenges have continued to drive restructurings in the marketing functions of many blue-chip customers of Xeim. This has led to the curtailment of marketing budgets and, although we have retained most of these customers, their spend has reduced. The prolonged impact of these challenges is materially reducing revenue and profit during the second half of 2024.

 

These headwinds are having a significant impact on Xeim's Econsultancy and Oystercatchers brands, and Xeim's non-strategic advertising revenue. More positively, revenue from our future growth drivers, The Lawyer, MW Mini MBA, Festival of Marketing's October event and Marketing Week's subscriptions, has continued to improve in the second half.

 

EBITDA in 2024 will decline as a result of the impact of the high operational gearing on Xeim's lower revenue and a change in revenue mix. EBITDA will also be lower than last year due to the 2024 planned £1.3m investment in product, marketing and resources set out in our BIG27 strategy. This will accelerate the growth of our strategically valuable revenue over the next three years, in particular from The Lawyer, MW Mini MBA and Marketing Week's subscriptions.

 

The Board now expects the Company to achieve revenue of at least £34m in 2024, at an adjusted EBITDA margin of approximately 15%, which is significantly below the current analyst consensus range. This revised expectation will also impact our revenue and profit expectations in 2025.

 

Outlook

We continue to review our go-to-market plans and maintain a focus on robust cost management. We retain a cautious outlook and do not anticipate that trading conditions for the affected parts of our business will improve in the near term.

 

Nonetheless, Centaur's strong balance sheet, with £9.5m of net cash at 30 September 2024, and reliable cash conversion from our strategically valuable revenue streams, means that we are well positioned to manage this uncertainty. We will also continue to invest behind our strategy, as this will generate long-term value, while maintaining our progressive dividend policy which, as previously announced, is paying an interim ordinary dividend of 0.6 pence per share later this month.

 

Enquiries

Centaur Media plc 020 7970 4000

Swag Mukerji, Chief Executive Officer

Simon Longfield, Chief Financial Officer

 

Teneo

 

Zoë Watt / Oliver Bell

07713 157561 / 07917 221748

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKARRSRURRUA
Date   Source Headline
1st May 201911:50 amRNSCentaur completes disposal of CTM
1st May 20197:00 amRNSCentaur completes disposal of HR business
30th Apr 20197:00 amRNSTotal Voting Rights
24th Apr 201911:09 amRNSDirector/PDMR Shareholding
18th Apr 20191:13 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSCentaur agrees sale of HR business
10th Apr 20197:00 amRNSCentaur agrees sale of CTM to Northstar
3rd Apr 201911:00 amRNSAnnual Financial Report
1st Apr 20197:00 amRNSCentaur sells financial services to Metropolis
29th Mar 20197:00 amRNSTotal Voting Rights
21st Mar 201910:06 amRNSDirector Declaration
20th Mar 201912:01 pmRNSDirector/PDMR Shareholding
20th Mar 20197:00 amRNSResults for the year ended 31 December 2018
28th Feb 20197:00 amRNSTotal Voting Rights
21st Feb 201910:26 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSTotal Voting Rights
22nd Jan 201911:33 amRNSDirector/PDMR Shareholding
22nd Jan 20197:00 amRNSCentaur's marketing division rebrands as XEIM
22nd Jan 20197:00 amRNSYear end trading update
2nd Jan 20197:00 amRNSTotal Voting Rights
19th Dec 20183:16 pmRNSDirector/PDMR Shareholding
30th Nov 20187:00 amRNSExtension of Existing Banking Facility
30th Nov 20187:00 amRNSTotal Voting Rights
20th Nov 20183:12 pmRNSDirector/PDMR Shareholding
19th Nov 20187:00 amRNSAppointment of advisers to assist with divestment
15th Nov 20184:40 pmRNSSecond Price Monitoring Extn
15th Nov 20184:35 pmRNSPrice Monitoring Extension
31st Oct 20187:00 amRNSTotal Voting Rights
25th Oct 20187:00 amRNSTrading Statement
25th Oct 20187:00 amRNSTrading update and accelerated simplification plan
24th Oct 20183:56 pmRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSTotal Voting Rights
21st Sep 20189:20 amRNSDirector/PDMR Shareholding
31st Aug 20187:00 amRNSTotal Voting Rights
21st Aug 20181:34 pmRNSDirector/PDMR Shareholding
3rd Aug 20187:00 amRNSDirectorate Change
31st Jul 20187:00 amRNSTotal Voting Rights
24th Jul 20187:00 amRNSInterim results for the 6 months ended 30 Jun 2018
20th Jul 201810:21 amRNSDirector/PDMR Shareholding
29th Jun 20187:00 amRNSTotal Voting Rights
20th Jun 201812:36 pmRNSDirector/PDMR Shareholding
31st May 20187:00 amRNSTotal Voting Rights
22nd May 201810:26 amRNSDirector/PDMR Shareholding
3rd May 20182:30 pmRNSResult of AGM
3rd May 20187:00 amRNSAGM Statement
30th Apr 20187:00 amRNSTotal Voting Rights
23rd Apr 201812:42 pmRNSDirector/PDMR Shareholding
9th Apr 20184:03 pmRNSDirector/PDMR Shareholding
9th Apr 20188:28 amRNSDirector/PDMR Shareholding
3rd Apr 20184:15 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.